Information  X 
Enter a valid email address

JPMorgan Chinese IT (JMC)

  Print      Mail a friend       Annual reports

Monday 28 January, 2019

JPMorgan Chinese IT

Results of Annual General Meeting

RNS Number : 3034O
JPMorgan Chinese Inv Tst PLC
28 January 2019
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN CHINESE INVESTMENT TRUST PLC

 

RESULTS OF 2019 ANNUAL GENERAL MEETING

 

Legal Entity Identifier: 549300S8M91P5FYONY25

 

Following the Annual General Meeting of the Company, which was held earlier today, the Board is pleased to announce that all the Ordinary Resolutions put to shareholders were passed.  In addition, the following items of Special Business were also passed which:

           

i.)          will allow the Company to allot shares up to an aggregate nominal amount of £1,817,579 representing approximately 10% of the Company's issued share capital;

 

ii.)         will allow the disapplication of pre-emption rights on the allotment of shares;  

 

iii.)        will allow the Company to make market purchases of up to 10,898,207 Ordinary shares representing 14.99% of the Company's issued share capital; and

 

iv.)        will amend the investment restrictions within the investment policy of the Company.

The full text of all the resolutions can be found in the Notice of Annual General Meeting contained in the Annual Report and Accounts which is available for viewing at the National Storage Mechanism which can be located at www.morningstar.co.uk/uk/NSM and from the Company's website www.jpmchinese.co.uk

A summary of proxy votes received will shortly be available on the Company's website, www.jpmchinese.co.uk 

 

28th January 2019

 

 

For further information, please contact:

 

Lucy Dina

For and on behalf of

JPMorgan Funds Limited, Secretary

020 7742 4000


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RAGSEWFDAFUSEIF

a d v e r t i s e m e n t